Time-delayed release of bioencapsulates: A novel controlled delivery concept for bone implant technologies
Chemistry of Materials, ISSN: 0897-4756, Vol: 20, Issue: 15, Page: 4826-4834
2008
- 37Citations
- 31Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Article Description
Vancomycin has been successfully entrapped into amino-polysiloxane matrixes via a one-step room-temperature sol-gel process, resulting in biodoped monolithic hybrid materials. The vancomycin-containing matrixes have been characterized by means of Fourier transform infrared (FTIR) and Si magic angle spinning nuclear magnetic resonance (Si MAS NMR) solid-state spectroscopies, evidencing the effective encapsulation of the drug. In vitro swelling behavior and delivery tests carried out under physiological conditions (37 °C, pH 7.4) showed not only the absence of burst effect but also, and remarkably, a zero-release period, or lag time, where no vancomycin was released to the medium during the first hours of assay. Subsequently, there was a sustained release of vancomycin over a prolonged period of days. This lag time is an essential requirement for implantable bioceramics that would allow the surgeon to perform the surgical procedure with zero drug release. The delivery behavior has been also tested mimicking bone infection conditions (37 °C, pH 6.5), and the lag time and subsequent sustained release are comparable to those obtained at physiological conditions, despite of the decrease of pH. This research work opens new possibilities for the design of novel time-delayed controlled delivery systems for bioencapsulates, useful in bone implant technologies. © 2008 American Chemical Society.
Bibliographic Details
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know